Are you Dr. Kern?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 55 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Crb1 Rm 451
1650 Orleans St
Baltimore, MD 21287Phone+1 410-514-3314Fax+1 443-287-4653
Summary
- Dr. Scott Kern, MD is a board certified pathologist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland and Michigan. He is affiliated with Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center.
Education & Training
Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 1987 - 1988
University of MichiganResidency, Pathology-Anatomic and Clinical, 1983 - 1986
University of Michigan Medical SchoolClass of 1983
Certifications & Licensure
MD State Medical License 1987 - 2026
MI State Medical License 1984 - 1988- American Board of Pathology Anatomic Pathology & Clinical Pathology
Awards, Honors, & Recognition
- Top Doctors:Baltimore Area Castle Connolly, 2012
- Top Doctors:Washington-Baltimore Castle Connolly, 2012
- Whos Who in Medicine and Healthcare Marquis Whos Who
Publications & Presentations
PubMed
- 839 citationsIdentification of p53 as a sequence-specific DNA-binding proteinScott E. Kern, Kenneth W. Kinzler, Arthur Bruskin, David E. Jarosz, Paula Friedman
Science. 1991-06-21 - 292 citationsWild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication.Jill Bargonetti, Paula N. Friedman, Scott E. Kern, Bert Vogelstein, Carol Prives
Cell. 1991-06-14 - 2962 citationsCore Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic AnalysesSiân Jones, Xiaosong Zhang, D. Williams Parsons, Jimmy Lin, Rebecca J. Leary
Science. 2008-09-26
Press Mentions
Local Car Club Chapter Raises $5800 for First RespondersMay 27th, 2021
Compounds in Saliva, Common Body Proteins May Fend off DNA-Damaging Chemicals in Tea, Coffee and Liquid SmokeMay 30th, 2014- Cancer Biologists Find DNA-Damaging Toxins in Common Plant-Based FoodsMarch 27th, 2013
- Join now to see all
Grant Support
- Discovery And Evaluation Of Prioritized Mutations In Pancreatic CancerNational Cancer Institute2009–2012
- High-Throughput Analysis Of Pancreatic Cancer MutationsNational Cancer Institute2009–2011
- Fanconi Defects In Pancreatic Cancer OncogenesisNational Cancer Institute2008–2011
- Pharmacodiagnotics Through Molecular CluesNational Cancer Institute2007–2011
- Career Development ProgramNational Cancer Institute2007–2011
- Administration And Communication CoreNational Cancer Institute2007–2011
- Spore In Gastrointestinal CancerNational Cancer Institute1999–2011
- Supplement: Screening For Early Pancreatic Neoplasia: A Multi-Center StudyNational Cancer Institute2007
- DPC4, Target Of 18q Deletion In Pancreatic CancerNational Cancer Institute2002–2006
- Spore In Gastrointestinal CancerNational Cancer Institute2002–2006
- New Genetic Clues For Pancreatic CancerNational Cancer Institute2002
- Components Of Early And LATE Pancreatic NeoplasiaNational Cancer Institute2002
- Targets For Screening In Pancreatic NeoplasiaNational Cancer Institute1997–2002
- New Genetic Markers For Pancreatic CancerNational Cancer Institute1997–2002
- DPC4 Target Of 18q Homozygous Deletions In Pancreatic CANational Cancer Institute1997–2001
- Genetic Alterations In Pancreatic Carcinoma And PrecursorsNational Cancer Institute1996
